New antibody HT31-1 enters human trials for ARDS
Disease control
Recruiting now
This early-stage trial tests a new antibody called HT31-1 in 24 healthy volunteers to see if it is safe and how the body processes it. The antibody targets a protein linked to inflammation in acute respiratory distress syndrome (ARDS), a severe lung condition often caused by infe…
Phase: PHASE1 • Sponsor: HTIC, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC